Recent Progress in the Development of Opaganib for the Treatment of Covid-19

Charles D Smith,1 Lynn W Maines,1 Staci N Keller,1 Vered Katz Ben-Yair,2 Reza Fathi,2 Terry F Plasse,2 Mark L Levitt2 1Apogee Biotechnology Corporation, Hummelstown, PA, USA; 2RedHill Biopharma LTD, Tel Aviv, IsraelCorrespondence: Charles D Smith, Apogee Biotechnology Corporation, 1214 Research Blvd...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Dove Medical Press 2022-07-01
Serie:	Drug Design, Development and Therapy
Ämnen:	opaganib abc294640 sphingolipid sphingosine kinase dihydroceramide desaturase glucosylceramide synthase
Länkar:	https://www.dovepress.com/recent-progress-in-the-development-of-opaganib-for-the-treatment-of-co-peer-reviewed-fulltext-article-DDDT
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!